Opioids and HIV/HCV infection

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) share transmission routes and risk factors, frequently co-infecting injection drug users (IDUs).
• IDUs are a major reservoir for HIV and HCV in the US, experiencing high rates of infectious disease morbidity and mortality.
• Opiate abuse, particularly heroin, is common among IDUs and may impact HIV pathogenesis by compromising immune responses.

Purpose of the Study:

• To explore the potential role of opiate abuse in facilitating the progression of HIV and/or HCV disease.
• To investigate the immunomodulatory and immunocompromising effects of opiates on viral infections.
• To highlight the need for further research into the mechanisms of opiate-mediated effects on host immunity and viral expression.

Main Methods:

• Review of existing in vitro, epidemiologic, and in vivo non-human primate studies on opiate abuse and HIV/HCV.
• Analysis of conflicting data regarding the impact of opiate abuse on HIV disease progression.
• Identification of knowledge gaps concerning the mechanisms of opiate-mediated immune modulation and viral enhancement.

Main Results:

• In vitro studies suggest morphine exacerbates HIV infection and replication.
• Epidemiologic and in vivo studies on opiate abuse and HIV progression have yielded conflicting results.
• Opiate abuse is hypothesized to facilitate HIV and/or HCV disease progression due to immunomodulatory effects.

Conclusions:

• Opiate abuse is a plausible facilitator of HIV and/or HCV disease progression.
• Further extensive studies are required to elucidate the mechanisms of opiate-mediated immune modulation.
• Understanding the role of opiates in modulating HIV/HCV progression is crucial for public health interventions in IDUs.